Optimistic Phase 2 Topaz Trial Extension Data Demonstrate Sizable And Sustained Motor Function Improvement At 24 Months With Apitegromab For Non-ambulatory Patients With Forms 2 And Three Spinal Muscular Atrophy Sma
Ask it to write you three paragraphs about the sequence of events on April 19, 1775, and it’ll...